You might be using an unsupported or outdated browser. To get the best possible experience please use the latest version of Chrome, Firefox, Safari, or Microsoft Edge ...

Shares in ImmunityBio rose sharply after the company said it has agreed a path with the FDA that will allow it to refile for approval of wider use of its bladder cancer therapy, Anktiva, in ...